Cargando…

Metformin and Colorectal Cancer Risk in Diabetic Patients

Detalles Bibliográficos
Autores principales:	Ioannou, George N., Boyko, Edward J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177744/ https://www.ncbi.nlm.nih.gov/pubmed/21949227 http://dx.doi.org/10.2337/dc11-1447

Ejemplares similares

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene
por: Anwar, M. Akhtar, et al.
Publicado: (2014)

Metformin improves diabetic kidney disease
por: Beladi Mousavi, Seyed Seifollah, et al.
Publicado: (2012)

Is It Time to Take a Different Approach to Screening People at High Risk for Type 1 Diabetes?
por: Boyko, Edward J., et al.
Publicado: (2009)

Metformin, aging and cancer
por: Moiseeva, Olga, et al.
Publicado: (2013)

Does Diabetes Always Confer Coronary Heart Disease Risk Equivalent to a Prior Myocardial Infarction?: Implications for prevention
por: Boyko, Edward J., et al.
Publicado: (2011)

Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018)

Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
por: Zhang, Yanfei, et al.
Publicado: (2013)

Metformin and Exercise in Cancer: Better Together
por: Stambolic, Vuk, et al.
Publicado: (2019)

The Anti-Diabetic Drug Metformin from the Neuropathy Perspective
por: Won, Jong Chul
Publicado: (2020)

Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients
por: Park, Jung Won, et al.
Publicado: (2017)

Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
por: Zhang, Zhi-Jiang, et al.
Publicado: (2011)

Risk of Cancer in Diabetes: The Effect of Metformin
por: Malek, Mojtaba, et al.
Publicado: (2013)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer
por: Dimberg, Jan, et al.
Publicado: (2022)

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
por: Tarhini, Zeinab, et al.
Publicado: (2022)

Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes
por: Demb, Joshua, et al.
Publicado: (2019)

Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
por: Papachristou, Stella, et al.
Publicado: (2021)

Metformin in breast cancer - an evolving mystery
por: Camacho, Laura, et al.
Publicado: (2015)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
por: Kim, Dong-Lim
Publicado: (2013)

Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Liu, Feifei, et al.
Publicado: (2016)

Risk of colorectal cancer in patients with diverticular disease
por: Meyer, Jeremy, et al.
Publicado: (2018)

Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
por: Hou, Yi-Chao, et al.
Publicado: (2016)

Metformin induces protein acetylation in cancer cells
por: Vancura, Ales, et al.
Publicado: (2017)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
por: Saito, Akira, et al.
Publicado: (2020)

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Long-term effects of metformin use in gestational diabetes mellitus on offspring health
por: Roy, Ayan, et al.
Publicado: (2021)

Metformin and the promise of geroprotection
por: Kalra, Sanjay, et al.
Publicado: (2012)

Metformin turns off the metabolic switch of pancreatic cancer
por: Deschênes-Simard, Xavier, et al.
Publicado: (2019)

Does Diabetes Really Impact on Postoperative Survival in Patients with Colorectal Cancer?
por: Kim, Hungdai
Publicado: (2010)

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019)

Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice
por: Al Kattar, Sahar, et al.
Publicado: (2020)

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014)

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
por: Wang, Yaodu, et al.
Publicado: (2017)

Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017)

Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer
por: Anisimov, Vladimir N.
Publicado: (2013)

Metformin, Cancer, Alphabet Soup, and the Role of Epidemiology in Etiologic Research
por: Duncan, Bruce B., et al.
Publicado: (2009)

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ksg1rfak523i56rn7ls6fn550t